Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The main objective of this clinical trial is to evaluate the effectiveness and
cost-effectiveness of adding ozone therapy to the clinical management of patients with pain
secondary to chemotherapy-induced peripheral neuropathy
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bernardino Clavo, MD, PhD
Collaborators:
Fundación DISA, Spain Fundación Española del Dolor (FED) Instituto de Salud Carlos III Red de Investigación en Servicios de Salud en Enfermedades Crónicas Servicio Canario de Salud